CI

At a glance

ClinicalIndex Comparison Record
Phase 4Unknown· 22 enrolled
Drug / intervention
ZOSTAVAXdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02444936
NCT02444936Phase 4Unknown
CompareCT.gov

A Pilot Study Using a Randomized Design to Evaluate the Immunologic Efficacy and Safety of ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Louis Stokes VA Medical Center·interventional·Posted May 15, 2015·Updated Apr 6, 2018

In Brief

A Phase 4 clinical trial evaluating ZOSTAVAX for Shingles. Targeting 22 participants.

Detailed Summary

This study evaluates if the shingles vaccine works in those persons that receive it before they receive chemotherapy for solid organ tumors. Half of the participants will receive the ZOSTAVAX shingle vaccine and half of the participants will not received anything.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsShingles
Countries--
CollaboratorsDuke University

Timeline

Phase 4UnknownOverdue
20162017201820192020202120222023202420252026
First PostedMay 15, 2015
Enrollment StartMay 1, 2015
Primary CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 11.1 years ago

Interventions

ZOSTAVAXdrug

Shingles vaccine